Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int
Clinical trial NCT03213964 · COMPLETED
Trial details
- NCT number
- NCT03213964
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-19
- Primary completion
- 2021-03-10
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.